Malignant peritoneal mesothelioma. Is there a new treatment?

Kakil Ibrahim Rasul; David J Kerr

doi:10.4081/rt.2009.e49

Rare Tumors (Dec 2009)

Malignant peritoneal mesothelioma. Is there a new treatment?

Kakil Ibrahim Rasul,
David J Kerr

Affiliations

Kakil Ibrahim Rasul: Al-Amal Hospital, Hamad Medical Corporation/Doha, Qatar
David J Kerr: Al-Sidra Research Center Doha, Qatar

DOI: https://doi.org/10.4081/rt.2009.e49
Journal volume & issue: Vol. 1

Abstract

Read online

The authors report a novel, alternative approach to treat malignant peritoneal mesothelioma (MPeM) targeting, vascular endothelial growth factor (VEGF) using anti-VEGF (bevacizumab) chemotherapy combination.

Published in Rare Tumors

ISSN: 2036-3605 (Print); 2036-3613 (Online)
Publisher: SAGE Publishing
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: http://journals.sagepub.com/home/rtu

About the journal